本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

BridgeBio Pharma, Inc.

56.63
+0.13000.23%
盤後57.050.4200+0.74%17:16 EDT
成交量:188.09萬
成交額:1.06億
市值:108.26億
市盈率:-13.83
高:57.49
開:56.63
低:55.71
收:56.50
52周最高:57.49
52周最低:21.72
股本:1.91億
流通股本:1.51億
量比:0.76
換手率:1.24%
股息:- -
股息率:- -
每股收益(TTM):-4.0935
每股收益(LYR):-2.8793
淨資產收益率:-1789.67%
總資產收益率:-41.96%
市淨率:-6.06
市盈率(LYR):-19.67

資料載入中...

2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/02

重要事件披露

Form 8-K - Current report
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities